[Form 4] Life360, Inc. Insider Trading Activity

Rhea-AI Filing Summary

John Philip Coghlan, a director of Life360, Inc. (LIF), reported securities transactions on a Form 4. On 08/15/2025 he sold 10,000 shares of Life360 common stock at a weighted average price of $85.01 per share, with sale prices in the range of $85.00 to $85.10. After the reported transactions the filing shows the reporting person beneficially owns 67,604 shares indirectly held by the John Philip Coghlan 2025 Grantor Retained Annuity Trust and 12,500 shares indirectly held by the John Coghlan Living Trust. The filing also records 3,344 restricted stock units (described as contingent rights to receive common shares upon vesting). The Form 4 is signed by an attorney-in-fact on 08/22/2025.

Positive

• Required disclosure provided: The Form 4 reports insider transactions and current beneficial ownership, ensuring regulatory transparency.
• Detailed pricing disclosure: The filing specifies a weighted average sale price ($85.01) and price range ($85.00 to $85.10) for the 10,000 shares sold.

Negative

• Insider disposition: The reporting person sold 10,000 shares on 08/15/2025, reducing reported holdings.
• Reduction in reported direct holdings: The filing records dispositions (including 3,344 RSUs shown as disposed) which change the composition of the reporting person’s potential future stake.

Insights

Financial Analyst

TL;DR: Director sold 10,000 shares at ~$85, reducing direct holdings; overall disclosed beneficial ownership remains material.

The reported sale of 10,000 shares on 08/15/2025 at a weighted average price of $85.01 is a clear insider disposition that may modestly change near-term insider holding dynamics but does not by itself disclose any change to company operations or financial performance. The filing shows 67,604 shares indirectly held in a grantor retained annuity trust and 12,500 shares in a living trust, and records 3,344 RSUs as contingent rights. This is routine Section 16 reporting of an insider sale and updated beneficial ownership totals.

Corporate Governance Expert

TL;DR: Form 4 provides required transparency on insider dispositions and trust holdings; no governance event or control shift is reported.

The disclosure documents an insider sale and lists indirect holdings through two trusts plus outstanding RSUs. There is no indication of a change in board membership, officer status, or any transfer that would suggest a governance change or 10% ownership threshold crossing. The signature by an attorney-in-fact is noted, consistent with authorized filing practice.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COGHLAN JOHN PHILIP

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		S		10,000	D	$85.01(1)	67,604	I	Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust
Common stock								3,344(2)	D
Common stock								12,500	I	Held by the John Coghlan Living Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.10, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

2. Reflects 3,344 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Remarks:

	/s/ Jay Sood, as Attorney-in-Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Life360 (LIF) report on this Form 4?

The filing reports that director John Philip Coghlan sold 10,000 shares of Life360 common stock on 08/15/2025 at a weighted average price of $85.01 per share.

How many Life360 shares does the reporting person beneficially own after the transaction?

After the reported transactions the filing shows 67,604 shares indirectly held by the John Philip Coghlan 2025 Grantor Retained Annuity Trust and 12,500 shares indirectly held by the John Coghlan Living Trust.

What are the 3,344 units mentioned in the Form 4?

The filing explains these are 3,344 restricted stock units, each a contingent right to receive one share of common stock upon vesting.

When was the Form 4 signed and by whom?

The form is signed by /s/ Jay Sood, as Attorney-in-Fact on 08/22/2025.

What price range were the 10,000 shares sold at?

The shares were sold in multiple transactions at prices ranging from $85.00 to $85.10 per share; the filing reports the weighted average price as $85.01.